DRKS00033250招募中不适用
PRospective Integrative Oncology Registry - PRIO
niversitätsklinik Ulm0 个研究点目标入组 100 人开始时间: 2023年12月18日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients diagnosed with cancer treated at the CCCU
- •Written informed consent
- •Ability to understand character and individual consequences of the clinical trial
排除标准
- •Clinically significant concomitant disease critically influencing the ability of the patient to protocol adequate behavior
- •Any finding that, in the judgment of the study investigator, renders the participant unsuitable for the study protocol
研究者
相似试验
招募中
Unknown
Multi-Centre Registry to assess clinical and quality of life outcomes in patients under going the Irreversible Electroporation (more commonly know as NanoKnife) procedureCancer - ProstateProstate CancerACTRN12623000859684St Vincent's Private Hospital500
尚未招募
Unknown
isting of all cancer patients at Balco Medical Centre.CTRI/2024/07/071650ICMR-NCDIR
招募中
不适用
A Construction of Cancer Registry and Prospective Korean Medicinal Cancer Cohort Study in East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University : Focused on Lung, Breast, Stomach, Colorectal, Liver, Uterine and Ovarian CancersNeoplasmsKCT0002160Dunsan Korean Medicine Hospital of Daejeon University172
已完成
不适用
Developing a Cancer database for Shirdi Sai Baba Cancer and Research Centre.CTRI/2018/10/016139Dr Kanav Khera Proff130
进行中（未招募）
不适用
18F-Fluorometilcholine (18F-FCH) PET/CT sensibility in diagnosing breast cancer metastasisde novo breast cancer metastasisMedDRA version: 14.0Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003036-31-ITAZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI50